Sanofi India Ltd.

SANOFI

₹5623.2

0.93% (51.85)

Market Cap

₹12,944 Cr.

P/E

31.32

About

Sanofi India Limited is a pharmaceutical company with a manufacturing facility in Goa and multiple third-party manufacturers across India. They offer a diverse portfolio of medications and dietary sup… Read more

Sanofi India Limited is a pharmaceutical company with a manufacturing facility in Goa and mult… Read more

Low

4902

52W Range

High

10525

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
ROE

Roe has decreased vs 10 year trend
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Market Share

6.24 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.32 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.05 %

(as of Mar 19)

Historic

Antineo Plastic - Market Share

1.97 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.55 %

(as of Mar 19)

Historic

Dermatology - Market Share

1.80 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

2.67 %

(as of Mar 19)

Historic

Neurological - Market Share

2.87 %

(as of Mar 19)

Historic

Pain - Market Share

1.60 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

3.38 %

(as of Mar 19)

Historic

Respiratory - Market Share

0.10 %

(as of Mar 19)

Historic

Sex Stimulants - Market Share

20.16 %

(as of Jul 22)

Historic

Vaccines - Market Share

0.12 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Allegra

Avil

Combiflam

Suppliers

Aarti Industries Ltd.
Shaily Engineering Plastics Ltd.
Aarti Drugs Ltd.
Vidhi Specialty Food Ingredients Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
HLE Glascoat Ltd.
NIIT Ltd.
Bliss GVS Pharma Ltd.
Wintac Ltd.
Take Solutions Ltd.

Showing 5 of 10

FAQs on Sanofi India Ltd. Business

What does Sanofi India do?

Sanofi India Limited sells a wide range of medications and dietary supplements for the treatment of various diseases in India. The company primarily operates through independent distributors.

Who are the competitors of Sanofi India?

Sanofi India major competitors are Jubilant Pharmova, Caplin Point Lab, Natco Pharma, Alembic Pharma, Marksans Pharma, Procter&Gamble Healt, Eris Lifesciences.
Market Cap of Sanofi India is ₹12,824 Crs.
While the median market cap of its peers are ₹13,982 Crs.

Is Sanofi India financially stable compared to its competitors?

Sanofi India seems to be less financially stable compared to its competitors.
Altman Z score of Sanofi India is 3.61 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini	Mar	Jun Sep Dec	Jun	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec

Discussions & Analysis

Sanofi India Ltd.

View the discussion on ValuePickr

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Sanofi India Ltd.